Blog

Honoring Steve Mathews’ 27-Year-Long Remarkable Journey – NFCR

NFCR/LinkedIn

Jul 17, 2025, 10:03

Honoring Steve Mathews’ 27-Year-Long Remarkable Journey – NFCR

National Foundation for Cancer Research (NFCR) shared a post on LinkedIn:

“Glioblastoma Awareness Day — a day to shed light on one of the most aggressive and deadly forms of brain cancer.

We’re honoring the legacy of Steve Mathews, who defied the odds after a GBM diagnosis and became a source of strength and hope for countless families.

Steve was given just two years to live… but lived 27 more—thanks to a clinical trial and an unshakable will to keep going.

On this day of awareness, let’s remember why research matters and why every moment gained is a victory.

Read Steve’s powerful story.”

Honoring Steve Mathews’ 27-Year-Long Remarkable Journey - NFCR

You can also read:

Glioblastoma Awareness Day 2025: Uniting for Progress and Hope

glioblastoma_OncoDaily

brain cancer cancer cancer awareness glioblastoma Glioblastoma Awareness Day National Foundation for Cancer Research NFCR OncoDaily Oncology Steve Mathews

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Yüksel Ürün: Science Is Better When It’s Shared